Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-933-8 | CAS number: 89-72-5
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
The substance is a monoconstituent with >98-100% (w/w) purity. The substance was evaluated according to latest Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.7c: Endpoint specific guidance; Version 2.0 November 2014).
The substance is liquid with a molecular weight between 150.2196g/mol, moderate water solubility of 1.46 g/L and log Pow = 3 at ambient conditions. The vapour pressure is low, i.e. 2.98 Pa = 2.24 x 10E-2mm Hg. Assessment of the molecular, physicochemical and toxicological properties leads to following conclusions:
- Oral/GI absorption:
Based upon the molecular structure and weight, moderate water solubility and high log Pow, and toxicological signs after oral dosing, oral absorption is most likely. From a conservative viewpoint, 100% oral absorption is considered.
- Respiratory absorption:
Based upon the low vapor pressure, evaporation and inhalation of the substance is unlikely. Deposition in the airways is therefore assumed to be absent and absorption by inhalation is considered to be negligible. From a conservative viewpoint, 30% inhalation absorption is considered.
- Dermal absorption:
Most of the physicochemical and toxicological parameters are in favour of dermal absorption. Dermal absorption is considered to be likely and comparable to oral absorption (100%). This is supported by an estimated dermally absorbed dose (DAD) of 6.2 mg/kg bw/day by means of Episuite Dermwin, which is considered substantial compared to DNELs.
For the assessment of distribution, metabolism and excretion physicochemical and toxicological properties are also taken into account, and following conclusions were deduced:
- Distribution:
Based upon the low molecular weight, high Log P and moderate water solubility, as well as target organs (liver and CNS), distribution is very likely.
- Metabolism & accumulation potential
For the various tissues mentioned, there is no direct indication of bioaccumulation potential.
- Excretion:
Excretion via the urine, breast milk and saliva/sweat are likely because of the ionisable structure, small molecular weight and moderate water solubility. Excretion via the air, bile, hair/nails and exfoliation are less likely.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 100
- Absorption rate - inhalation (%):
- 30
Additional information
More detailed information is given in the Basic Toxicokinetics assessment attached.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
